{"disease":{"id":"lymphoma-non-hodgkin","name":"lymphoma non hodgkin"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04996706","title":"Evaluation of Lymphoma Prognosis and Survivorship in Recently Diagnosed Patients, LEO Study","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":21000,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT04971304","title":"Comparative Effectiveness Analysis of Granulocyte Colony Stimulating Factor Originator Products Versus Biosimilars","phase":"","overall_status":"COMPLETED","enrollment_count":16506,"lead_sponsor_name":"Catherine M. Lockhart","has_results":false},{"nct_id":"NCT01584141","title":"Study of Lymphoma in Asia","phase":"","overall_status":"COMPLETED","enrollment_count":13433,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT03131531","title":"Bergamo Lymphoid Cancer Registry","phase":"","overall_status":"RECRUITING","enrollment_count":6000,"lead_sponsor_name":"A.O. Ospedale Papa Giovanni XXIII","has_results":false},{"nct_id":"NCT06573099","title":"A Real-World Study on Extranodal Lymphoma","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Ruijin Hospital","has_results":false},{"nct_id":"NCT01196520","title":"Epidemiology of Burkitt Lymphoma in East Africa Children or Minors (EMBLEM)","phase":"","overall_status":"COMPLETED","enrollment_count":4893,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT02693535","title":"TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":4200,"lead_sponsor_name":"American Society of Clinical Oncology","has_results":false},{"nct_id":"NCT00626496","title":"Family Study of Lymphoproliferative Disorders","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT06002828","title":"Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"ECOG-ACRIN Cancer Research Group","has_results":false},{"nct_id":"NCT06203652","title":"The Pathogenesis and Prognostic Factors of Lymphoma","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Shanghai Zhongshan Hospital","has_results":false},{"nct_id":"NCT03546101","title":"Early Detection of Epstein-Barr Virus Related Disease.","phase":"","overall_status":"COMPLETED","enrollment_count":1527,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT03050268","title":"Familial Investigations of Childhood Cancer Predisposition","phase":"","overall_status":"RECRUITING","enrollment_count":1500,"lead_sponsor_name":"St. Jude Children's Research Hospital","has_results":false},{"nct_id":"NCT03155620","title":"Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1377,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT00339963","title":"Genome Expression in Lymphoma, Leukemia and Multiple Myeloma","phase":"","overall_status":"COMPLETED","enrollment_count":1340,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT01676805","title":"Tissue Collection for Studies of Lymph Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":1295,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT06541327","title":"Cellular Immunotherapy for Relapsed or Refractory Lymphoma Data Collection","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Ruijin Hospital","has_results":false},{"nct_id":"NCT05556720","title":"Bringing Optimised COVID-19 Vaccine Schedules To ImmunoCompromised Populations (BOOST-IC): an Adaptive Randomised Controlled Clinical Trial","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":960,"lead_sponsor_name":"Monash University","has_results":false},{"nct_id":"NCT00897325","title":"Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma","phase":"","overall_status":"COMPLETED","enrollment_count":811,"lead_sponsor_name":"Children's Oncology Group","has_results":false},{"nct_id":"NCT03297606","title":"Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":720,"lead_sponsor_name":"Canadian Cancer Trials Group","has_results":false},{"nct_id":"NCT02500407","title":"A Safety, Efficacy and Pharmacokinetic Study of BTCT4465A (Mosunetuzumab) as a Single Agent and Combined With Atezolizumab in Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":713,"lead_sponsor_name":"Genentech, Inc.","has_results":false},{"nct_id":"NCT03289182","title":"An Observational Study of MabThera Subcutaneous (SC) Safety in Participants With Non-Hodgkin's Lymphoma (NHL) or Chronic Lymphocytic Leukemia (CLL)","phase":"","overall_status":"COMPLETED","enrollment_count":701,"lead_sponsor_name":"Hoffmann-La Roche","has_results":false},{"nct_id":"NCT03117036","title":"Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study III","phase":"","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"Samsung Medical Center","has_results":false},{"nct_id":"NCT01787409","title":"Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":565,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT02626455","title":"Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":551,"lead_sponsor_name":"Bayer","has_results":true},{"nct_id":"NCT00840047","title":"Methionine PET/CT Studies In Patients With Cancer","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":503,"lead_sponsor_name":"St. Jude Children's Research Hospital","has_results":false},{"nct_id":"NCT01996865","title":"Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":503,"lead_sponsor_name":"Celgene","has_results":true},{"nct_id":"NCT02682667","title":"Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT03375619","title":"Long-term Follow-up Study of Patients Receiving CAR-T Cells","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Medical College of Wisconsin","has_results":false},{"nct_id":"NCT03958916","title":"Prospective Multicenters Clinical Cohort Study of Stratified Treatment of Chinese Children With BL/DLBCL","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT04077723","title":"A Study to Evaluate the Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Englumafusp Alfa in Combination With Obinutuzumab and in Combination With Glofitamab Following a Pre-Treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":498,"lead_sponsor_name":"Hoffmann-La Roche","has_results":false},{"nct_id":"NCT02367040","title":"Copanlisib and Rituximab in Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (iNHL)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":458,"lead_sponsor_name":"Bayer","has_results":true},{"nct_id":"NCT01777152","title":"ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":452,"lead_sponsor_name":"Seagen Inc.","has_results":true},{"nct_id":"NCT05421663","title":"A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin Lymphoma","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":439,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":false},{"nct_id":"NCT03930953","title":"A Safety and Preliminary Efficacy Study of CC-99282, Alone and in Combination With Anti-lymphoma Agents in Participants With Relapsed or Refractory Non-Hodgkin Lymphomas (R/R NHL)","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":438,"lead_sponsor_name":"Celgene","has_results":false},{"nct_id":"NCT06564038","title":"A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":408,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT05968001","title":"Obinutuzumab in Chinese Real-world Patients With iNHL","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":400,"lead_sponsor_name":"Affiliated Hospital of Nantong University","has_results":false},{"nct_id":"NCT04090268","title":"Precision Exercise in Children With Malignant Hemopathies","phase":"NA","overall_status":"UNKNOWN","enrollment_count":380,"lead_sponsor_name":"University of Milano Bicocca","has_results":false},{"nct_id":"NCT03984448","title":"Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas","phase":"PHASE2, PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":363,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT04748185","title":"Immunogenicity and Safety of Commercially Available Vaccines Against SARS-CoV-2 (COVID-19) in Patients With Hematologic Malignancies","phase":"","overall_status":"COMPLETED","enrollment_count":358,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT01938001","title":"Rituximab Plus Lenalidomide for Patients With Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (Follicular Lymphoma and Marginal Zone Lymphoma)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":358,"lead_sponsor_name":"Celgene","has_results":true},{"nct_id":"NCT04537871","title":"Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":350,"lead_sponsor_name":"City of Hope Medical Center","has_results":false},{"nct_id":"NCT03366272","title":"Nivolumab With Gemcitabine, Oxaliplatin + Rituximab in r/r Elderly Lymphoma Patients","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":348,"lead_sponsor_name":"Universität des Saarlandes","has_results":false},{"nct_id":"NCT01232556","title":"A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":338,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT01799889","title":"Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacodynamics of Entospletinib in Adults With Relapsed or Refractory Hematologic Malignancies","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":326,"lead_sponsor_name":"Gilead Sciences","has_results":true},{"nct_id":"NCT03971305","title":"A Prospective Multicenters Clinical Cohort Study of Stratified Treatment of Chinese Children With Systemic ALK(+) ALCL","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT05114330","title":"Secondary Central Nervous System Lymphoma Registry - Charité","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Charite University, Berlin, Germany","has_results":false},{"nct_id":"NCT05746858","title":"Predictive Biomarkers Including miRNA-based Tumor Signatures in Diffuse Large B Cell Lymphoma (R/R DLBCL) (MIMOSA)","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT03314974","title":"Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Masonic Cancer Center, University of Minnesota","has_results":false},{"nct_id":"NCT03971318","title":"A Prospective Multicenters Clinical Cohort Study of Stratified Treatment of Chinese Children With LBL","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT03229200","title":"Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":297,"lead_sponsor_name":"Pharmacyclics Switzerland GmbH","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}